Catostylus mosaicus an autoimmune stimulant


  • Project code: PRJ-000835

  • Project stage: Closed

  • Project start date: Monday, April 16, 2007

  • Project completion date: Friday, May 30, 2008

  • National Priority: NAP-Provide new and developing animal industries with regular and up-to-date market assessments


New and Emerging Animal Industries

Research Organisation


Objective Summary

Finalise project QUT-8A . Investigate the potential commercial development of therapeutic products from Catostylus mosaicus . Establish handling and processing procedures . Identify the class(es) of active components . Determine degree of activity (o r range of activity through bioassay) . Gather sufficient data to make Go/No Go decisions for commercial development